107 related articles for article (PubMed ID: 7858466)
1. [The antithrombotic and thrombolytic activity of a plasminogen activator isolated from a monolayer cell culture].
Liapina LA; Pastorova VE; Koval'chuk GA; Leĭkina MI; Leĭkina GA; Poliakova IA
Izv Akad Nauk Ser Biol; 1994; (3):468-71. PubMed ID: 7858466
[TBL] [Abstract][Full Text] [Related]
2. [Fibrinolytic and thrombolytic properties of a plasminogen activator isolated from the culture broth of calf kidney cells].
Egorov BB; Andreenko GV; Liaginskiĭ AV; Stelingovskií KV; Podorol'skaia LV
Farmakol Toksikol; 1983; 46(4):54-6. PubMed ID: 6684592
[TBL] [Abstract][Full Text] [Related]
3. [Plasminogen activator from a kidney cell culture].
Andreenko GV; Egorov BB; Liaginskiĭ AV; Serebriakova TN; Podorol'skaia LV
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (10):55-8. PubMed ID: 6686063
[TBL] [Abstract][Full Text] [Related]
4. New strategies in the development of thrombolytic agents.
Lijnen HR; Collen D
Curr Stud Hematol Blood Transfus; 1991; (58):69-72. PubMed ID: 1954777
[No Abstract] [Full Text] [Related]
5. Evaluation of epithelial tissue plasminogen activator as a thrombolytic agent in a rabbit model of venous thrombosis.
Electricwala A; Emeis JJ; Atkinson T
J Pharmacol Exp Ther; 1986 Jul; 238(1):254-8. PubMed ID: 2425075
[TBL] [Abstract][Full Text] [Related]
6. [The thrombolytic activity of acylated activator complexes of plasmin-streptokinase with different rates of reactivation].
Bashkov GV; Aĭsina RB; Kazanskaia NF; Makarov VA; Sirotenko AV; Popova GIu; Zhitkova IuV
Farmakol Toksikol; 1991; 54(2):46-50. PubMed ID: 1884796
[TBL] [Abstract][Full Text] [Related]
7. Serine-proteases as plasminogen activators in terms of fibrinolysis.
Flemmig M; Melzig MF
J Pharm Pharmacol; 2012 Aug; 64(8):1025-39. PubMed ID: 22775207
[TBL] [Abstract][Full Text] [Related]
8. [Tissue plasminogen activator].
Matsuo O
Rinsho Ketsueki; 1984 Jul; 25(7):1004-10. PubMed ID: 6542154
[No Abstract] [Full Text] [Related]
9. Thrombolytic and Antiplatelet Effects of a Novel Plasminogen Activator from the Venom of Gloydius Brevicaudus Viper.
Zhang Z; Lin L; Zhang J; Zhang Q; Zhao N; Wu L; Chen J; Wu Z; Wu G; Lin J; Chen Y; Xu Y
J Atheroscler Thromb; 2015; 22(10):1080-90. PubMed ID: 26004931
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic activity of two chimeric recombinant plasminogen activators (FK2tu-PA and K2tu-PA) in rabbits.
Agnelli G; Pascucci C; Colucci M; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1992 Sep; 68(3):331-5. PubMed ID: 1440500
[TBL] [Abstract][Full Text] [Related]
11. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
12. Human extrinsic plasminogen activator fibrinolytic properties and neutralization in vivo.
Mattsson C; Nilsson S; Häggroth L
Thromb Res; 1983 Apr; 30(1):91-100. PubMed ID: 6683005
[TBL] [Abstract][Full Text] [Related]
13. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of placental plasminogen activator (PPA).
Kobayashi T; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
[TBL] [Abstract][Full Text] [Related]
15. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
17. [Plasminogen activators and their physiological role].
Andreenko GV
Ukr Biokhim Zh (1978); 1983; 55(3):329-43. PubMed ID: 6346623
[No Abstract] [Full Text] [Related]
18. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D
Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163
[TBL] [Abstract][Full Text] [Related]
19. A model system for the in vivo determination of the thrombolytic effect of plasminogen activators.
Scheu JD; Jing SL; Bruckner-Kardoss E; Gargan PE; Pollard M
Thromb Res; 1988 Aug; 51(4):391-402. PubMed ID: 3187963
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological potentials for activating the fibrinolytic system].
Markwardt F
Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
